Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  BioDrugs

• Publication date

  2016-02-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40259-016-0160-yPMID 26902608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Teaching the basics of autophagy and mitophagy to redox biologists—Mechanisms and experimental approaches

  2015cited by this paper
• Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro

  2015cited by this paper
• DRAM1 regulates apoptosis through increasing protein levels and lysosomal localization of BAX

  2015cited by this paper
• Autophagy in cancer

  2015cited by this paper
• Current evidence of temozolomide and bevacizumab in treatment of gliomas

  2015cited by this paper
• A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells

  2015cited by this paper
• Knockdown of AKT3 and PI3KCA by RNA interference changes the expression of the genes that are related to apoptosis and autophagy in T98G glioblastoma multiforme cells

  2015cited by this paper
• Molecular mechanisms of apoptosis and roles in cancer development and treatment.

  2015cited by this paper
• Autophagy: Detection, regulation and its role in cancer and therapy response

  2014cited by this paper
• Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells.

  2014cited by this paper
• Autophagy and Cancer Therapy

  2014cited by this paper
• Autosis and autophagic cell death: the dark side of autophagy

  2014cited by this paper
• Knockdown of AKT3 (PKB γ) and PI3KCA Suppresses Cell Viability and Proliferation and Induces the Apoptosis of Glioblastoma Multiforme T98G Cells

  2014cited by this paper
• Temozolomide induces autophagy via ATM‑AMPK‑ULK1 pathways in glioma.

  2014cited by this paper
• The Impact of Autophagy on Cell Death Modalities

  2014cited by this paper
• AMP kinase (PRKAA1)

  2014cited by this paper
• Role of the Crosstalk between Autophagy and Apoptosis in Cancer

  2013cited by this paper
• Autophagy: A critical regulator of cellular metabolism and homeostasis

  2013cited by this paper
• Ambra1 at the crossroad between autophagy and cell death

  2013cited by this paper
• Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?

  2013cited by this paper
• Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment

  2013cited by this paper
• Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway

  2013cited by this paper
• The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells

  2013cited by this paper
• Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage

  2013cited by this paper
• Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells

  2013cited by this paper
• Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line

  2013cited by this paper
• Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding

  2013cited by this paper
• UVRAG: at the crossroad of autophagy and genomic stability.

  2012cited by this paper
• DRAM-1 encodes multiple isoforms that regulate autophagy

  2012cited by this paper
• The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.

  2012cited by this paper
• Current clinical development of PI3K pathway inhibitors in glioblastoma.

  2012cited by this paper
• [Autophagy--molecular mechanism, apoptosis and cancer].

  2012cited by this paper
• Wilms’ tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression

  2011cited by this paper
• Effect of temozolomide on the U-118 glioma cell line.

  2011cited by this paper
• Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).

  2011cited by this paper
• The Beclin 1 network regulates autophagy and apoptosis

  2011cited by this paper
• Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks

  2011cited by this paper
• Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells

  2011cited by this paper
• A critical role for UVRAG in apoptosis

  2011cited by this paper
• ULK1 inhibits the kinase activity of mTORC1 and cell proliferation

  2011cited by this paper
• BCL2L1 (BCL2-like 1)

  2011cited by this paper
• Akt2 and Akt3 play a pivotal role in malignant gliomas.

  2010cited by this paper
• [Akt kinase: a key regulator of metabolism and progression of tumors].

  2010cited by this paper
• Mammalian autophagy: core molecular machinery and signaling regulation.

  2010cited by this paper
• Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis

  2010cited by this paper
• Autophagy is a therapeutic target in anticancer drug resistance.

  2010cited by this paper
• Current Perspectives on Akt Akt-ivation and Akt-ions

  2009cited by this paper
• Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells.

  2009cited by this paper
• Role of ULK-FIP200 complex in mammalian autophagy: FIP200, a counterpart of yeast Atg17?

  2009cited by this paper
• Regulation mechanisms and signaling pathways of autophagy.

  2009cited by this paper
• An Atg1/Atg13 complex with multiple roles in TOR-mediated autophagy regulation.

  2009cited by this paper
• Does autophagy have a license to kill mammalian cells?

  2009cited by this paper
• Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.

  2008cited by this paper
• The autophagy effector Beclin 1: a novel BH3-only protein

  2008cited by this paper
• Sugar and fat – that's where it's at: metabolic changes in tumors

  2008cited by this paper
• Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

  2008cited by this paper
• Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: a comparison with standard photometric methods

  2008cited by this paper
• Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas.

  2007cited by this paper
• Ambra1 regulates autophagy and development of the nervous system

  2007cited by this paper
• Crystal Structure of the Bcl-XL-Beclin 1 Peptide Complex

  2007cited by this paper
• Autophagic programmed cell death by selective catalase degradation.

  2006cited by this paper
• Bcl-2 inhibition of autophagy: a new route to cancer?

  2006cited by this paper
• Autophagy and Cancer Therapy

  2006cited by this paper
• Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.

  2005cited by this paper
• The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death

  2005cited by this paper
• Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3

  2005cited by this paper
• Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence.

  2005cited by this paper
• The role of autophagy in cancer development and response to therapy

  2005cited by this paper
• Inhibition of Macroautophagy Triggers Apoptosis

  2005cited by this paper
• Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Lysosomes and autophagy in cell death control

  2005cited by this paper
• Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

  2004cited by this paper
• Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes

  2004cited by this paper
• Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells

  2003cited by this paper
• Flow Cytometry

  2002cited by this paper
• Synergistic Effect of Genistein and BCNU on Growth Inhibition and Cytotoxicity of Glioblastoma Cells

  2002cited by this paper
• Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.

  2001cited by this paper
• Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

  1999cited by this paper
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

  1998cited by this paper
• Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.

  1996cited by this paper
• Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly

  1996cited by this paper
• T98G: An anchorage‐independent human tumor cell line that exhibits stationary phase G1 arrest in vitro

  1979cited by this paper

• MMADPE: drug repositioning based on multi-hop graph Mamba aggregation with dual-modality graph positional encoding.

  2025cites this paper
• The effect of combination therapy on Bevacizumab, Carmustine, and Metformin chemotherapy drugs on the fluctuating performance expression of TLR2, TLR6, and IL-6 genes in the cell line of brain glioblastoma

  2025cites this paper
• RNA Interference of the Genes Associated with the Invasion of Brain Tumor Cells

  2025cites this paper
• The mTOR pathway in Gliomas: From molecular insights to targeted therapies.

  2025cites this paper
• Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta

  2024cites this paper
• Glioblastoma therapy: State of the field and future prospects.

  2024cites this paper
• Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?

  2022cites this paper
• AKT3 and related molecules as potential biomarkers responsible for cryptorchidism and cryptorchidism-induced azoospermia

  2021cites this paper
• Circ_0016760 accelerates non‐small‐cell lung cancer progression through miR‐646/AKT3 signaling in vivo and in vitro

  2021cites this paper
• Molecular mechanisms in temozolomide-resistant glioblastoma

  2021cites this paper
• Role of apoptosis, autophagy, and the unfolded protein response in glioblastoma chemoresistance

  2021cites this paper
• Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems.

  2021cites this paper
• Co-delivery of AKT3 siRNA and PTEN Plasmid by Antioxidant Nanoliposomes for Enhanced Antiproliferation of Prostate Cancer Cells.

  2020cites this paper
• Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma

  2019cites this paper
• Precision Revisited: Targeting Microcephaly Kinases in Brain Tumors

  2019cites this paper
• The dual roles of autophagy in gliomagenesis and clinical therapy strategies based on autophagic regulation mechanisms.

  2019cites this paper
• MicroRNA‑494 promotes the proliferation and migration of human glioma cancer cells through the protein kinase B/mechanistic target of rapamycin pathway by phosphatase and tensin homolog expression.

  2018cites this paper
• MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3

  2018cites this paper
• Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.

  2018cites this paper
• The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma

  2017cites this paper
• MicroRNA-338-3 p inhibits thyroid cancer progression through targeting AKT 3

  2017cites this paper
• Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

  2017cites this paper
• MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

  2017cites this paper
• Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer

  2017cites this paper
• Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line.

  2017cites this paper
• Identification of Significant Pathways Induced by PAX5 Haploinsufficiency Based on Protein-Protein Interaction Networks and Cluster Analysis in Raji Cell Line

  2017cites this paper